Xtant Medical Holdings, Inc.

AMEX:XTNT

Medical - Devices

Healthcare
$0.36 -0.16%

-$0.00 today

Market cap
$50.37M
Beta
-0.17
P/E (TTM)
33.4
EPS (TTM)
$0.01
52W Low $0.40High $0.95

Volume 0.16M

Average 0.16M

XTNT Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

Xtant Medical Holdings, Inc.AMEX: XTNT

Change in Working Capital · Q1 FY2026 · quarter ended Mar 2026

Change in working capital growth accelerates

Q1 FY2026 change in working capital of $1.52M (cash outflow) rose 0.3% year over year, ahead of the -5.7% change in trailing-twelve-month change in working capital. Over 3 fiscal years it compounded at +2.7% a year.

Context

  • Change in working capital amounted to 2.3% of revenue in FY2025, down 2.3 pp from a year earlier.
  • Change in working capital grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +0.3% holds above the trailing-twelve-month pace of -5.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$1.52M-158.0% QoQ
Last fiscal yearDec 2025
-$3.05M-43.1% YoY
LTMMar 2026
-$3.05M-5.7% YoY
Change in Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.3%——
1 year-43.1%——
3-year CAGR+2.7%——
5-year CAGR——
10-year CAGR——

Change in Working Capital history

USD · from the cash flow

Latest · FY2025
(3.05M) USD
Year-over-year change
+43.1%

Change in Working Capital vs competitors

How XTNT compares with its peers on the latest reported figures

  • XTNT's LTM Mar 2026 change in working capital of $3.05M is the 5th largest of the 8 companies compared; the peer median is $289K.
  • Its year-over-year change of -5.7% is the 5th highest of 8, against a peer median of +28.5%.
  • Change in working capital amounts to 2.5% of revenue for XTNT, versus a peer median of 6.3%.
XTNT Competitors Peer median
Change in Working Capital for XTNT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FONRFONAR CorporationLTM Mar 2026$6.67M -20.7%-16.8%6.3%
APYXApyx Medical CorporationLTM Mar 2026$3.4M -235.0%-32.7%6.1%
LUCDLucid Diagnostics Inc.LTM Mar 2026$3.16M +28.5%—61.5%
RPIDRapid Micro Biosystems, Inc.LTM Mar 2026$3.13M +392.8%—9.1%
XTNTXtant Medical Holdings, Inc.LTM Mar 2026$3.05M -5.7%+2.7%2.5%
RCELAVITA Medical, Inc.LTM Mar 2026$967K -46.5%—1.3%
EXOZeXoZymes, Inc.LTM Mar 2026$300.58K +106.3%——
VANIVivani Medical, Inc.LTM Mar 2026$289K +2123.1%-12.2%—
Peer median (excluding XTNT) $289K+28.5%-16.8%6.3%

Competitors are the stored peer set for XTNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(4.85M)(8.49M)660K(16.45M)4.97M
Depreciation & Amortization1.33M1.29M3.17M4.22M5.22M
Deferred Income Tax00(1.9M)21K0
Stock-Based Compensation2.21M2.46M2.74M4.12M2.89M
Change in Working Capital793K(2.81M)(3.63M)(5.35M)(3.05M)
Accounts Receivables(319K)(3.94M)(8.74M)(755K)(591K)
Inventory2.62M(1.15M)(1.89M)(2.49M)(2M)
Accounts Payables(332K)875K2.98M1.03M(3.12M)
Other Working Capital(1.18M)1.41M4.01M(3.13M)2.66M
Other Non-Cash Items954K2.2M(10.55M)1.54M2.5M
Operating Cash Flow439K(5.34M)(9.52M)(11.9M)12.55M
Capital Expenditures(2.12M)(1.76M)(1.46M)(4.11M)(2.38M)
Acquisitions (Net)00(23.5M)00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities225K205K175K383K10.28M
Investing Cash Flow(1.89M)(1.56M)(24.78M)(3.73M)7.9M
Debt Repayment(592K)(291K)6.18M12.43M(9.33M)
Common Stock Issued18.43M9.31M14.01M4.46M0
Common Stock Repurchased0000(65K)
Dividends Paid00000
Other Financing Activities(337K)9.07M(500K)(816K)(175K)
Financing Cash Flow17.5M9.02M19.69M16.07M(9.57M)
Effect of Forex Changes0024K(149K)232K
Net Change in Cash16.05M2.12M(14.58M)298K11.11M
Free Cash Flow(1.68M)(7.11M)(10.97M)(16.01M)10.16M

Xtant Medical Holdings, Inc.

AMEX:XTNT

Intrinsic Alpha fair value

Locked

Current Price

$0.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.